Lupin announced that the US FDA inspected companys Nagpur Unit-2 injectable manufacturing facility from 17 October 2022 to 29 October 2022 The inspection was a Pre-Approval Inspection of the injectable facility The inspection closed with issuance of a Form-483 with five observations The company said that it is committed to addressing the observations at the earliest and gaining approval for injectable manufacturing for the US
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
